Clinical trials
ARDS (Moderate or Severe) clinical trials
Below are recruiting ards (moderate or severe) clinical trials, each written for real people, not researchers. We’re tracking 1,504 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07013201RecruitingPhase 2
Testing a new cream for palmoplantar pustulosis
This trial tests a cream called delgocitinib for people with mild to severe palmoplantar pustulosis (PPP), a skin condition with pustules on the palms and soles. The cream is applied daily for 16 weeks to see if it improves symptoms and is safe.
Fountain Valley, CaliforniaAges 18 years+ - NCT04124341Recruiting
Brain stimulation for treatment-resistant depression
This study tests a new brain stimulation treatment for people with severe depression that hasn't improved with standard treatments. You must have tried at least four different depression treatments without success, and either had or refused electroconvulsive therapy (ECT). You’ll need to be under a psychiatrist’s care and be enrolled in Medicare. The study involves brain scans and EEG sessions to tailor the treatment to you.
Minneapolis, MinnesotaAges 22–70 - NCT06736574RecruitingPhase 3
Study of omecamtiv mecarbil for chronic heart failure with very weak heart pump
This study tests an investigational medicine (omecamtiv mecarbil) for people with chronic heart failure and very low pumping strength. It looks at whether the drug can help prevent heart failure events or the need for stronger treatments.
Alexander City, AlabamaAges 18–85 - NCT07215949RecruitingPhase 3
Zilucoplan for severe myasthenia gravis flare-ups
This trial tests zilucoplan, a daily injection, to treat severe muscle weakness from myasthenia gravis that requires hospital care. It may help you recover faster and avoid needing a breathing tube.
Tampa, FloridaAges 18 years+ - NCT07789301Recruiting
Predicting severe pain after planned cesarean with spinal anesthesia
This study looks at how to predict severe pain after a planned cesarean delivery done under spinal anesthesia. It aims to find factors that may help doctors better manage pain after surgery.
Bursa, NilüferAges 18–45 - NCT07749716RecruitingPhase 2
Oral tablet for severe hair loss
This study tests an experimental oral tablet for severe alopecia areata, a condition that causes patches of hair to fall out. The goal is to see if it can help regrow hair safely. You may be able to join if you have this type of hair loss and meet the health requirements.
Beijing, Beijing MunicipalityAges 18–65 - NCT07787793Recruiting
Effects of non-invasive brain stimulation on hand movement after stroke
This study tests whether a non-invasive brain stimulation technique called repetitive transcranial magnetic stimulation (rTMS) can help improve hand movement in people who have had a stroke and have severe arm weakness. It uses a special device to stimulate the brain and may help with motor recovery.
Palma, Balearic IslandsAges 18 years+ - NCT06123988Recruiting
Fasting and exercise for advanced breast cancer
This study looks at whether fasting overnight and/or doing exercise can help improve fatigue and other quality-of-life measures in women with advanced hormone receptor positive breast cancer who are already taking a CDK4/6 inhibitor. Participation may involve following a fasting or exercise plan for a period of time.
Phoenix, ArizonaAges 18 years+ - NCT07786870Recruiting
Understanding airway proteins in asthma
This study examines a protein called TSLP that may play a role in asthma inflammation. By looking at different versions of TSLP in your airway samples, researchers hope to learn more about asthma and potentially guide future treatments.
Warsaw, WarsawAges 18 years+ - NCT07772492RecruitingPhase 3
Study of upadacitinib for teens with severe hair loss
This study tests if upadacitinib can help young people with severe alopecia areata (a condition causing patchy hair loss) regrow their hair. It may be an option if hair loss has been present for less than 8 years and there has been no recent improvement.
Miami, FloridaAges 6–17 - NCT07743580RecruitingPhase 3
Secutrelvir for covid-19 patients at high risk
This trial tests a new antiviral pill, secutrelvir, for people with mild to moderate covid-19 who are at higher risk of getting seriously ill. It aims to see if the drug can prevent hospitalization or severe disease.
Coral Gables, FloridaAges 12 years+ - NCT07782281Recruiting
Early discharge with home care after weight-loss surgery
This study compares early discharge from the hospital with follow-up care at home versus the usual hospital stay after bariatric (weight-loss) surgery. It aims to see if going home early with home care is safe and reduces costs.
Sabadell, BarcelonaAges 18–65 - NCT07753876Enrolling by invitation
Cuffless blood pressure monitoring during dialysis
This study tests a wearable device that measures blood pressure without a cuff while you are on dialysis. It may give a more comfortable way to track your blood pressure during treatment.
SeoulAges 19 years+ - NCT07053800RecruitingPhase 2
Obe-cel for severe lupus with kidney inflammation
This trial tests a new cell therapy called obe-cel in people ages 12 to 65 with severe systemic lupus erythematosus (SLE) that has not responded to other treatments and has caused active lupus nephritis (kidney disease). The goal is to see if obe-cel can reduce lupus activity and improve kidney health.
New York, New YorkAges 12–65 - NCT07013474RecruitingPhase 3
Study of ibuzatrelvir for immunocompromised adults with COVID-19
This trial tests an investigational medicine called ibuzatrelvir for adults with COVID-19 who have a weakened immune system. The study aims to see if it helps them recover and avoid severe illness.
Canoga Park, CaliforniaAges 18 years+ - NCT07775794Recruiting
Moderate exercise for quiet bowel disease
This study looks at whether a moderate exercise program can help people with inflammatory bowel disease (IBD) feel better and manage their condition. It aims to see if exercise improves overall health without worsening symptoms.
Bangkok Noi, BangkokAges 18–65 - NCT07777744Recruiting
Study of serious complications during heart rhythm procedure
This study looks at the serious risks of a procedure that treats irregular heartbeats. It aims to understand how often complications happen and what they are, which can help doctors improve safety.
Chicago, IllinoisAges 18 years+ - NCT06575426RecruitingPhase 1/Phase 2
Pig pancreatic cell transplant for type 1 diabetes
This trial tests a new treatment made from pig pancreatic cells (called OPF-310) that are placed under the skin to help control blood sugar in people with type 1 diabetes. It is for those whose diabetes is difficult to manage and who have dangerous low blood sugar episodes.
Chicago, IllinoisAges 35–70 - NCT06309238Recruiting
Intensive diet vs. surgery for severe obesity
This study compares two programs for people with severe obesity: an intensive weight-loss diet and a weight-loss surgery (bariatric surgery). It aims to see which approach works better for long-term health.
AarhusAges 18–60 - NCT05909748Recruiting
First-in-human test of a new TAVR valve for severe aortic narrowing
This trial tests a new heart valve replacement (TAVR) system in people with severe, symptomatic aortic stenosis. If you qualify, it may offer a less invasive option compared with open-heart valve surgery, while also helping researchers understand safety and early effectiveness.
Petah TikvaAges 18–120 - NCT05835271Enrolling by invitation
Hip exoskeleton to help walking in severe lung disease
This trial tests a powered hip exoskeleton device to improve walking ability in people with stable, severe lung-related breathing problems. It may help you walk farther or more comfortably by supporting your movement, as long as your heart, blood pressure, and skin/body fit are safe for the device.
Toronto, OntarioAges 18 years+ - NCT05844462RecruitingPhase 3
Tadalafil for severe lung blood-pressure problems from COPD
This study tests whether tadalafil can improve outcomes for people with severe pulmonary hypertension caused by COPD (chronic lung disease). It compares how you do with tadalafil versus standard care, focusing on breathing symptoms and how well your heart and lungs cope.
Le Kremlin-Bicêtre, FranceAges 18–85 - NCT05801224Recruiting
Vascular ARDS recruitment after inhaled nitric oxide
This study tests whether giving nitric oxide gas through a breathing tube helps people with a lung condition called ARDS (acute respiratory distress syndrome) recover and leave the intensive care unit sooner. It may help some patients with mild-to-moderate cases who need a ventilator and a central line.
Boston, MassachusettsAges 18–80 - NCT07549178Recruiting
Mobile monitoring and care coordination for serious mental illness
This study tests whether combining extra care coordination with tracking data from your smartphone can help improve mental health care and reduce hospital visits. Researchers will use your smartphone to monitor your wellbeing while a care coordinator helps connect you with the support you need.
West Los Angeles, CaliforniaAges 18 years+
Hear when a new ARDS (Moderate or Severe) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for ards (moderate or severe)?
- Yes. Clin2 currently lists 1,504 recruiting ards (moderate or severe) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a ards (moderate or severe) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a ards (moderate or severe) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.